ArticleOncoTargets and therapy2013

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer.

Eftimia Boutsikou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.